NovoCure

NovoCure NVCR Stock

$17.19   4.881032%
Add to favorites
Market Cap
$2.00B
LOW - HIGH [24H]
$16.27 - $17.19
VOLUME [24H]
$166.29K
P/E Ratio
0
Earnings per share
-$1.30
ISIN
JE00BYSS4X48
Price   Prediction

NovoCure Price Chart

Sorry, that's all we've gotfor now...

NovoCure NVCR Financial and Trading Overview

NovoCure stock price 17.19 USD
Previous Close 15.69 USD
Open 15.99 USD
Bid 11.72 USD x 200
Ask 20.48 USD x 200
Day's Range 15.77 - 16.42 USD
52 Week Range 9.82 - 21.45 USD
Volume 1.53M USD
Avg. Volume 1.7M USD
Market Cap 1.91B USD
Beta (5Y Monthly) 0.984
PE Ratio (TTM) N/A
EPS (TTM) -1.3 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 27.14 USD

NVCR Valuation Measures

Enterprise Value 1.7B USD
Trailing P/E N/A
Forward P/E -20.07668
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 2.7296429
Price/Book (mrq) 5.643939
Enterprise Value/Revenue 2.433
Enterprise Value/EBITDA -12.474

Trading Information

NovoCure Stock Price History

Beta (5Y Monthly) 0.984
52-Week Change 50.36%
S&P500 52-Week Change 21.71%
52 Week High 21.45 USD
52 Week Low 9.82 USD
50-Day Moving Average 16.35 USD
200-Day Moving Average 13.84 USD

NVCR Share Statistics

Avg. Volume (3 month) 1.7M USD
Avg. Daily Volume (10-Days) 1.44M USD
Shares Outstanding 116.45M
Float 93.85M
Short Ratio 6.36
% Held by Insiders 9.95%
% Held by Institutions 86.81%
Shares Short 11.46M
Short % of Float 13.30%
Short % of Shares Outstanding 9.84%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2025
Most Recent Quarter (mrq) June 30, 2026
Next Fiscal Year End December 31, 2026

Profitability

Profit Margin -21.24%
Operating Margin (ttm) -5.75%
Gross Margin 76.37%
EBITDA Margin -19.50%

Management Effectiveness

Return on Assets (ttm) -9.25%
Return on Equity (ttm) -43.21%

Income Statement

Revenue (ttm) 699.19M USD
Revenue Per Share (ttm) 6.16 USD
Quarterly Revenue Growth (yoy) 15.59%
Gross Profit (ttm) 533.98M USD
EBITDA -136392992 USD
Net Income Avi to Common (ttm) -148564992 USD
Diluted EPS (ttm) -1.3
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 440.56M USD
Total Cash Per Share (mrq) 3.78 USD
Total Debt (mrq) 233.42M USD
Total Debt/Equity (mrq) 69.04 USD
Current Ratio (mrq) 2.893
Book Value Per Share (mrq) 2.904

Cash Flow Statement

Operating Cash Flow (ttm) -2815000 USD
Levered Free Cash Flow (ttm) 22.76M USD

Profile of NovoCure

Country United States
State N/A
City Baar
Address Neuhofstrasse 21
ZIP 6340
Phone N/A
Website https://www.novocure.com
Industry Medical Devices
Sector(s) Healthcare
Full Time Employees 1605

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, France, Japan, Greater China, and internationally. Its TTFields devices include Optune Gio, Optune Lua, and Optune Pax. The company also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Baar, Switzerland.

Q&A For NovoCure Stock

What is a current NVCR stock price?

NovoCure NVCR stock price today per share is 17.19 USD.

How to purchase NovoCure stock?

You can buy NVCR shares on the Tech Market Large exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for NovoCure?

The stock symbol or ticker of NovoCure is NVCR.

Which industry does the NovoCure company belong to?

The NovoCure industry is Medical Devices.

How many shares does NovoCure have in circulation?

The max supply of NovoCure shares is 116.45M.

What is NovoCure Price to Earnings Ratio (PE Ratio)?

NovoCure PE Ratio is now.

What was NovoCure earnings per share over the trailing 12 months (TTM)?

NovoCure EPS is -1.3 USD over the trailing 12 months.

Which sector does the NovoCure company belong to?

The NovoCure sector is Healthcare.

NovoCure NVCR included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.symbol }} {{ item.name }} {{ item.symbol }} {{ item.country.toUpperCase() }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
us US Tech Composite IXIC US 26712.8 USD
+0.08
2.41B USD 26603.13 USD 26724.63 USD 2.41B USD
us US Tech Next Generation 100 Inde NGX US 1874.08 USD
+0.07
1869.87 USD 1879.31 USD
us US Tech Biotechnology NBI US 6837.1 USD
+0.81
6792.25 USD 6849.94 USD
us US Tech Health Care IXHC US 1302.18 USD
+0.7
1292.71 USD 1303.19 USD
us US Tech Composite Total Return XCMP US 32954.54 USD
+0.07
32825.4 USD 32975.31 USD
us US Tech Global Select Market Com NQGS US 13114.81 USD
+0.07
13062.75 USD 13123.11 USD
us US Tech DM Ex Japan Large Mid Ca NQDMXJPLMAUD US 2100.38 AUD 1467.26 USD
<0.01
2100.38 AUD 1467.26 USD 2100.38 AUD 1467.26 USD
us Stlmt ID US Tech Biotechnology NBX US 3995.9 USD
-4.37
4555.41 USD 4917.8 USD
us US Tech US Smart Pharmaceuticals NQSSPH US 2117.72 USD
+0.68
2101.43 USD 2120.48 USD
us US Tech AlphaDEX Multi Cap Growt NQDXUSMLTCG US 4105.24 USD
+0.07
4092.49 USD 4110.72 USD
$2.29T
Total marketcap
$45.23B
Total volume
BTC 56.64%     ETH 9.98%
Dominance
Select currency